Peter Heerma
Corporate Officer/Principal bij TRAVERE THERAPEUTICS, INC.
Vermogen: 767 168 $ op 31-03-2024
Profiel
Peter Heerma is currently the Chief Commercial Officer at Travere Therapeutics, Inc. Prior to this, he worked as the Director of Commercial Strategy Renal Care at Abbott Laboratories from 2003 to 2012, Senior Director of Portfolio Strategy at AbbVie, Inc. from 2012 to 2015, and General Manager of Oncology & Cardiovascular Products at Amgen, Inc. from 2015 to 2019.
He received his graduate degree from the University of Lund in 1997 and his undergraduate degree from Stenden University in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2024 | 99 503 ( 0.13% ) | 767 168 $ | 31-03-2024 |
Actieve functies van Peter Heerma
| Bedrijven | Functie | Begin |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2019 |
Eerdere bekende functies van Peter Heerma
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01-09-2019 |
| ABBVIE INC. | Corporate Officer/Principal | 01-11-2015 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-11-2012 |
Opleiding van Peter Heerma
| University of Lund | Graduate Degree |
| Stenden University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| AMGEN INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
